US and EU Clinical Development Plans
(World News Science)

Ovoca Bio plc (`Ovoca` or the `Company`) US and EU Clinical Development PlanS Ovoca Bio plc (LSE: OVB; ISE: OVXA) is pleased to announce that its subsidiary IVIX LLC (`IVIX`) has commenced the process of preparing an integrated Clinical Development Plan (`CDP`) for its investigational drug candidate, Libicore (BP-101), for both the US and EU regions with Biorasi LLC (`Biorasi`), an experienced US-based contract research organization. The Medical and Scientific Affairs team from Biorasi will lead the preparation of the integrated CDP for inclusion in the clinical section of the submission dossiers under the Scientific Advice procedure at the German Federal Institute for Drugs and...